MYCN amplification and ATRX mutations are incompatible in neuroblastoma

In most cancers, mutations that lead to oncogene activation and tumor suppressor inactivation synergize to promote tumorigenesis. However, in neuroblastomas, MYCN amplification and ATRX mutations are mutually exclusive and incompatible.

Guardado en:
Detalles Bibliográficos
Autores principales: Maged Zeineldin, Sara Federico, Xiang Chen, Yiping Fan, Beisi Xu, Elizabeth Stewart, Xin Zhou, Jongrye Jeon, Lyra Griffiths, Rosa Nguyen, Jackie Norrie, John Easton, Heather Mulder, Donald Yergeau, Yanling Liu, Jianrong Wu, Collin Van Ryn, Arlene Naranjo, Michael D. Hogarty, Marcin M. Kamiński, Marc Valentine, Shondra M. Pruett-Miller, Alberto Pappo, Jinghui Zhang, Michael R. Clay, Armita Bahrami, Peter Vogel, Seungjae Lee, Anang Shelat, Jay F. Sarthy, Michael P. Meers, Rani E. George, Elaine R. Mardis, Richard K. Wilson, Steven Henikoff, James R. Downing, Michael A. Dyer
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/08a87c1bf95d4f798e9e0d5a7daabd61
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:08a87c1bf95d4f798e9e0d5a7daabd61
record_format dspace
spelling oai:doaj.org-article:08a87c1bf95d4f798e9e0d5a7daabd612021-12-02T16:56:32ZMYCN amplification and ATRX mutations are incompatible in neuroblastoma10.1038/s41467-020-14682-62041-1723https://doaj.org/article/08a87c1bf95d4f798e9e0d5a7daabd612020-02-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-14682-6https://doaj.org/toc/2041-1723In most cancers, mutations that lead to oncogene activation and tumor suppressor inactivation synergize to promote tumorigenesis. However, in neuroblastomas, MYCN amplification and ATRX mutations are mutually exclusive and incompatible.Maged ZeineldinSara FedericoXiang ChenYiping FanBeisi XuElizabeth StewartXin ZhouJongrye JeonLyra GriffithsRosa NguyenJackie NorrieJohn EastonHeather MulderDonald YergeauYanling LiuJianrong WuCollin Van RynArlene NaranjoMichael D. HogartyMarcin M. KamińskiMarc ValentineShondra M. Pruett-MillerAlberto PappoJinghui ZhangMichael R. ClayArmita BahramiPeter VogelSeungjae LeeAnang ShelatJay F. SarthyMichael P. MeersRani E. GeorgeElaine R. MardisRichard K. WilsonSteven HenikoffJames R. DowningMichael A. DyerNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-20 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Maged Zeineldin
Sara Federico
Xiang Chen
Yiping Fan
Beisi Xu
Elizabeth Stewart
Xin Zhou
Jongrye Jeon
Lyra Griffiths
Rosa Nguyen
Jackie Norrie
John Easton
Heather Mulder
Donald Yergeau
Yanling Liu
Jianrong Wu
Collin Van Ryn
Arlene Naranjo
Michael D. Hogarty
Marcin M. Kamiński
Marc Valentine
Shondra M. Pruett-Miller
Alberto Pappo
Jinghui Zhang
Michael R. Clay
Armita Bahrami
Peter Vogel
Seungjae Lee
Anang Shelat
Jay F. Sarthy
Michael P. Meers
Rani E. George
Elaine R. Mardis
Richard K. Wilson
Steven Henikoff
James R. Downing
Michael A. Dyer
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
description In most cancers, mutations that lead to oncogene activation and tumor suppressor inactivation synergize to promote tumorigenesis. However, in neuroblastomas, MYCN amplification and ATRX mutations are mutually exclusive and incompatible.
format article
author Maged Zeineldin
Sara Federico
Xiang Chen
Yiping Fan
Beisi Xu
Elizabeth Stewart
Xin Zhou
Jongrye Jeon
Lyra Griffiths
Rosa Nguyen
Jackie Norrie
John Easton
Heather Mulder
Donald Yergeau
Yanling Liu
Jianrong Wu
Collin Van Ryn
Arlene Naranjo
Michael D. Hogarty
Marcin M. Kamiński
Marc Valentine
Shondra M. Pruett-Miller
Alberto Pappo
Jinghui Zhang
Michael R. Clay
Armita Bahrami
Peter Vogel
Seungjae Lee
Anang Shelat
Jay F. Sarthy
Michael P. Meers
Rani E. George
Elaine R. Mardis
Richard K. Wilson
Steven Henikoff
James R. Downing
Michael A. Dyer
author_facet Maged Zeineldin
Sara Federico
Xiang Chen
Yiping Fan
Beisi Xu
Elizabeth Stewart
Xin Zhou
Jongrye Jeon
Lyra Griffiths
Rosa Nguyen
Jackie Norrie
John Easton
Heather Mulder
Donald Yergeau
Yanling Liu
Jianrong Wu
Collin Van Ryn
Arlene Naranjo
Michael D. Hogarty
Marcin M. Kamiński
Marc Valentine
Shondra M. Pruett-Miller
Alberto Pappo
Jinghui Zhang
Michael R. Clay
Armita Bahrami
Peter Vogel
Seungjae Lee
Anang Shelat
Jay F. Sarthy
Michael P. Meers
Rani E. George
Elaine R. Mardis
Richard K. Wilson
Steven Henikoff
James R. Downing
Michael A. Dyer
author_sort Maged Zeineldin
title MYCN amplification and ATRX mutations are incompatible in neuroblastoma
title_short MYCN amplification and ATRX mutations are incompatible in neuroblastoma
title_full MYCN amplification and ATRX mutations are incompatible in neuroblastoma
title_fullStr MYCN amplification and ATRX mutations are incompatible in neuroblastoma
title_full_unstemmed MYCN amplification and ATRX mutations are incompatible in neuroblastoma
title_sort mycn amplification and atrx mutations are incompatible in neuroblastoma
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/08a87c1bf95d4f798e9e0d5a7daabd61
work_keys_str_mv AT magedzeineldin mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT sarafederico mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT xiangchen mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT yipingfan mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT beisixu mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT elizabethstewart mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT xinzhou mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT jongryejeon mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT lyragriffiths mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT rosanguyen mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT jackienorrie mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT johneaston mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT heathermulder mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT donaldyergeau mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT yanlingliu mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT jianrongwu mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT collinvanryn mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT arlenenaranjo mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT michaeldhogarty mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT marcinmkaminski mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT marcvalentine mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT shondrampruettmiller mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT albertopappo mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT jinghuizhang mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT michaelrclay mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT armitabahrami mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT petervogel mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT seungjaelee mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT anangshelat mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT jayfsarthy mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT michaelpmeers mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT raniegeorge mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT elainermardis mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT richardkwilson mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT stevenhenikoff mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT jamesrdowning mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
AT michaeladyer mycnamplificationandatrxmutationsareincompatibleinneuroblastoma
_version_ 1718382780300132352